COMPOSÉS D'OLIGONUCLÉOTIDES DE RÉGULATION IMMUNE (IRO) PERMETTANT DE MODULER UNE RÉPONSE IMMUNE FONDÉE SUR UN RÉCEPTEUR DE TYPE TOLL

• 收藏
• 分享

专利权人:

Inc.;Idera Pharmaceuticals

发明人:

申请号：

EP17166068.1

公开号：

EP3213770A1

申请日:

2011.11.18

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/